Date: January 12, 2021
https://content.jwplatform.com/videos/AWTgROeV-gJjLxEC2.mp4
Moneta Porcupine Mines holds a 100% interest in 6 core gold projects
strategically located along the Destor-Porcupine Fault Zone in the
Timmins Gold Camp.
In Canada’s most prolific gold mining region
Moneta Porcupine Mines holds a 100% interest in 6 core gold projects and
one joint venture strategically located along the Destor-Porcupine
Fault Zone in the Timmins Gold Camp with over 85 million ounces of past
gold production.
The main Golden Highway Project covers 12 km of prospective ground along
the DPFZ of which 4 km hosts the December 2020 43-101 mineral resource
estimate comprised of an indicated resource of 2,145,000 ounces gold
contained within 55.3 Mt @ 1.21 g/t Au and a total of 3,337,000 ounces
gold contained within 49.7 Mt @ 2.09 g/t Au in the inferred category at
a 2.60 g/t Au at South West, 3.00 g/t Au cut-off for the other
underground deposits and 0.30 g/t Au for the open pit deposits.
For more information on Moneta Porcupine Mines Inc. (TSX: ME,
OTC: MPUCF) please fill out the form below.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160332680
Recent ME News
- Potter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach Case • Business Wire • 04/30/2024 03:00:00 PM
- 23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- 23andMe announces CEO’s intention to pursue a potential take-private • GlobeNewswire Inc. • 04/18/2024 12:00:00 PM
- 23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 • GlobeNewswire Inc. • 04/05/2024 08:05:00 PM
- 23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6 • GlobeNewswire Inc. • 03/20/2024 11:30:00 AM
- 23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago • GlobeNewswire Inc. • 03/19/2024 12:00:00 PM
- 23andMe Launches New Genetic Reports on Common Forms of Cancer • GlobeNewswire Inc. • 03/06/2024 12:30:00 PM
- 23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:36:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/07/2024 09:07:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:03:56 PM
- 23andMe Reports Third Quarter Fiscal 2024 Financial Results • GlobeNewswire Inc. • 02/07/2024 09:01:00 PM
- Moneta Gold and Nighthawk Gold Complete At-Market Merger to form STLLR Gold Inc. • Business Wire • 02/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 12:50:09 PM
- 23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay • GlobeNewswire Inc. • 01/31/2024 03:12:36 AM
- Nighthawk Gold Obtains Final Court Order for the Proposed Arrangement • Business Wire • 01/30/2024 10:00:00 PM
- 23andMe to Report FY2024 Third Quarter Financial Results • GlobeNewswire Inc. • 01/24/2024 09:05:00 PM
- Moneta Gold and Nighthawk Gold Announce the Proposed Directors for the MergeCo Board • Business Wire • 01/22/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:45:21 PM
- 23andMe announces further expansion of 23ME-00610 Phase 1/2a clinical trial in advanced neuroendocrine and ovarian cancer patient cohorts • GlobeNewswire Inc. • 12/19/2023 01:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/01/2023 09:06:04 PM
- Nighthawk and Moneta Announce At-Market Merger to Create a Leading Canadian Gold Development Company • Business Wire • 11/28/2023 12:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 09:41:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 09:40:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:06:11 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM